UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549
                           FORM 10-QSB

(Mark One)

[X]               QUARTERLY  REPORT  PURSUANT  TO SECTION 13
                  OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                  1934

For the quarterly period ended: June 30, 2003

Or

[ ]               TRANSITION  REPORT  PURSUANT TO SECTION 13
                  OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                  1934

For the transition period from ____________ to _____________

Commission File Number: 000-33187

                         CareDecision Corporation
          (Exact name of registrant as specified in its charter)

                    Nevada                         91-2105842
       (State or other jurisdiction of          (I.R.S. Employer
        incorporation or organization)         Identification No.)

2660 Townsgate Road, Westlake Village, Suite 300, CA 91361        91361
        (Address of principal executive offices)                (Zip Code)

                         (805) 446-1973
      (Registrant's telephone number, including area code)

     2 Penn Plaza, 15th Floor, Suite 1500-53, New York, NY, 10121
          (Former name, former address and former fiscal year,
                    if changed since last report)

 Indicate by check mark whether the registrant (1) has filed all
   reports required to be filed by Section 13 or 15(d) of the
 Securities Exchange Act of 1934 during the preceding 12 months
 (or for such shorter period that the registrant was required to
   file such reports), and (2) has been subject to such filing
               requirements for the past 90 days.
                         Yes [X] No [ ]

  APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                DURING THE PRECEDING FIVE YEARS:
   Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or
 15(d) of the Securities Exchange Act of 1934 subsequent to the
  distribution of securities under a plan confirmed by a court.
                         Yes [ ] No [ ]

              APPLICABLE ONLY TO CORPORATE ISSUERS:
The number of shares outstanding of each of the issuer's classes
     of common stock as of the most recent practicable date:
                           86,606,012


/1/


                       CareDecision Corporation
                   [formerly ATR Search Corporation]
                     (a Development Stage Company)


                           Table of Contents

                                                                      Page

PART I - FINANCIAL INFORMATION

  Item 1. Financial Statements                                          3

    Independent Accountant's Review Report                              4

    Consolidated Balance Sheet June 30, 2003 (unaudited)                5

    Consolidated Statements of Operations For the Three and Six         6
    Months Ended June 30, 2003 and 2002 (unaudited) and For the
    Period July 6, 2000 (Inception) to June 30, 2003 (unaudited)

    Consolidated Statements of Cash Flows For the Six Months            7
    Ended June 30, 2003 and 2002 (unaudited) and For the Period
    July 6, 2000 (Inception) to June 30, 2003 (unaudited)

    Notes to Financial Statements                                       8

  Item 2. Management's Discussion and Plan of Operation                11

PART II - OTHER INFORMATION

  Item 6. Exhibits                                                     15

SIGNATURES                                                             16


/2/


Part I - Financial Information

     Item 1. Financial Statements






                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)

                   Consolidated Balance Sheet
                              as of
                    June 30, 2003 (unaudited)

                               and

              Consolidated Statements of Operations
               for the Three and Six Months Ended
               June 30, 2003 and 2002 (unaudited),
                       and For the Period
      July 6, 2000 (Inception) to June 30, 2003 (unaudited)

                               and

              Consolidated Statements of Cash Flows
                    for the Six Months Ended
               June 30, 2003 and 2002 (unaudited),
                       and For the Period
      July 6, 2000 (Inception) to June 30, 2003 (unaudited)


/3/


Beckstead and Watts, LLP
Certified Public Accountants
                                          3340 Wynn Road, Suite B
                                              Las Vegas, NV 89102
                                                     702.257.1984
                                                 702.362.0540 fax


             INDEPENDENT ACCOUNTANT'S REVIEW REPORT

Board of Directors
CareDecision Corporation
(formerly ATR Search Corporation)
(a Development Stage Company)
New York, NY

We  have  reviewed the accompanying balance sheet of CareDecision
Corporation   (formerly   ATR  Search  Corporation)   (a   Nevada
corporation)  (a development stage company) as of June  30,  2003
and  the  related statements of operations for the three and  six
months  ended June 30, 2003 and 2002 and for the period  July  6,
2000  (Inception) to June 30, 2003, and statements of cash  flows
for  the  six  months ended June 30, 2003 and 2002  and  for  the
period  July  6,  2000  (Inception)  to  June  30,  2003.   These
financial  statements  are the responsibility  of  the  Company's
management.

We conducted our reviews in accordance with standards established
by  the  American Institute of Certified Public  Accountants.   A
review  of interim financial information consists principally  of
applying  analytical  procedures to financial  data,  and  making
inquiries  of  persons responsible for financial  and  accounting
matters.   It  is  substantially less  in  scope  than  an  audit
conducted   in   accordance  with  generally  accepted   auditing
standards,  which will be performed for the full  year  with  the
objective  of  expressing  an  opinion  regarding  the  financial
statements taken as a whole.  Accordingly, we do not express such
an opinion.

Based   on  our  reviews,  we  are  not  aware  of  any  material
modifications  that should be made to the accompanying  financial
statements  referred to above for them to be in  conformity  with
generally accepted accounting principles in the United States  of
America.

The accompanying financial statements have been prepared assuming
the  Company  will continue as a going concern.  As discussed  in
Note  2  to the financial statements, the Company has had limited
operations  and  has not commenced planned principal  operations.
This raises substantial doubt about its ability to continue as  a
going concern.  Management's plans in regard to these matters are
also  described  in  Note  2.  The financial  statements  do  not
include  any  adjustments that might result from the  outcome  of
this uncertainty.

We  previously  audited,  in accordance with  generally  accepted
auditing standards, the balance sheet of CareDecision Corporation
(formerly  ATR Search Corporation) (a development stage  company)
as   of  December  31,  2002,  and  the  related  statements   of
operations,  stockholders' equity, and cash flows  for  the  year
then  ended (not presented herein) and in our report dated  April
4,  2003,  we expressed an unqualified opinion on those financial
statements.

/s/ Beckstead and Watts, LLP

August 12, 2003


/4/


                         CareDecision Corporation
                     [formerly ATR Search Corporation]
                       (a Development Stage Company)
                        Consolidated Balance Sheet
                                (unaudited)



                                                                  June 30,
  Assets                                                            2003
                                                              -------------
     Current assets:
       Cash and equivalents                                   $      11,913
                                                              -------------
          Total current assets                                       11,913
                                                              -------------

     Fixed assets, net                                            1,319,386
                                                              -------------

                                                              $   1,331,299
                                                              =============

     Liabilities and Stockholders' Equity

     Current liabilities:
       Note payable to shareholder                            $      79,657
       Notes payable                                                567,517
                                                              -------------
          Total current liabilities                                 647,174
                                                              -------------

     Convertible notes - related party                               13,548
                                                              -------------

                                                                    660,722
                                                              -------------

     Stockholders' equity:
       Preferred stock, $0.001 par value, 5,000,000 shares
         authorized, no shares issued and outstanding                     -
       Common stock, $0.001 par value, 200,000,000 shares
         authorized, 86,606,012 shares issued and outstanding        86,606
       Additional paid-in capital                                 3,608,941
       Treasury stock                                               (96,750)
       (Deficit) accumulated during development stage            (2,928,220)
                                                              -------------
                                                                    670,577
                                                              -------------

                                                              $   1,331,299
                                                              =============



 The accompanying notes are an integral part of these financial statements.


/5/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)
                     Consolidated Statements of Operations
                                  (unaudited)


                               For the            For the
                             three months        six months       July 6, 2000
                            ended June 30,      ended June 30,   (Inception) to
                        -------------------  ------------------     June 30,
                            2003      2002     2003      2002         2003
                        ---------  --------  -------- ---------  -------------
                                  (Restated)          (Restated)   (Restated)

Revenue                $    1,350 $       - $   1,850 $   1,055   $      3,850
                        ---------  --------  -------- ---------  -------------

Expenses:
 General and
  administrative
  expenses                 45,111     3,720    83,989   182,849        166,675
 Payroll expense           63,913         -   122,794         -        309,613
 Professional fees         12,658         -    43,228         -        215,080
 Consulting expense       125,000   290,000   356,000   409,446      1,675,482
 Software development       2,950         -     3,950         -        132,950
 Depreciation              80,623         -   165,652     1,393        326,418
                        ---------  --------  -------- ---------  -------------
    Total expenses        330,255   293,720   775,613   593,688      2,826,218
                        ---------  --------  -------- ---------  -------------

Other income (expenses):
 (Loss) on debt
  settlement              (37,094)        -   (37,094)        -        (63,019)
 Interest income                1         -       561       967          2,791
 Interest (expense)       (11,981)        -   (22,804)   (8,251)       (45,624)
                        ---------  --------  -------- ---------  -------------

Net (loss)              $(377,979)$(293,720)$(833,100)$(599,917)  $ (2,928,220)
                        =========  ========  ======== =========  =============

Weighted average
number of
common shares
outstanding -
basic and fully
diluted               84,432,887 21,891,703 83,473,288 10,822,178
                      ========== ========== ========== ==========

Net (loss) per share -
basic and fully
diluted               $   (0.00) $   (0.01) $   (0.01) $   (0.06)
                      ========== ========== ========== ==========



 The accompanying notes are an integral part of these financial statements.


/6/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)
                     Consolidated Statements of Cash Flows
                                  (unaudited)



                                 For the six months ended      July 6,2000
                                         June 30,            (inception) to
                                --------------------------      June 30,
                                    2003          2002            2003
                                ------------  ------------   --------------

Cash flows from operating
 activities
Net (loss)                      $   (833,100) $   (599,917)  $   (2,928,220)
Shares issued for services           356,000       409,446        1,675,482
Loss on debt settlement               37,094             -           63,019
Depreciation                         165,652         1,393          326,418
Adjustments to reconcile net
 (loss) to net cash (used)
 by operating activities:
  (Increase) decrease in notes
   receivable                          5,376       (24,900)               -
  Decrease in loan to officer         10,999             -                -
Net cash (used) by operating    ------------  ------------   --------------
 activities                         (257,979)     (213,978)        (863,301)
                                ------------  ------------   --------------

Cash flows from financing
 activities
  Proceeds from convertible
  notes - related party               50,000             -           50,000
  Proceeds from notes payable              -       537,573          536,722
  Proceeds from note payable
   to shareholder                    113,791             -           79,657
  Payments on note payable
   to shareholder                     (5,000)      (20,000)         (31,165)
  Issuance of common stock                 -             -          240,000
Net cash provided by financing  ------------  ------------   --------------
 activities                          158,791       517,573          875,214
                                ------------  ------------   --------------

Net increase in cash                 (99,188)      303,595           11,913
Cash - beginning                     111,101             4                -
                                ------------  ------------   --------------
Cash - ending                   $     11,913  $    303,599   $       11,913
                                ============  ============   ==============

Supplemental disclosures:
  Interest paid                 $          -  $          -   $            -
                                ============  ============   ==============
  Income taxes paid             $          -  $          -   $            -
                                ============  ============   ==============

Non-cash transactions:
  Number of shares issued for
   services provided               8,000,000    12,440,000       27,617,737
                                ============  ============   ==============
  Number of shares issued to
   acquire technology              2,500,000             -        2,500,000
                                ============  ============   ==============
  Number of shares issued for
   debt settlement                   741,875             -          741,875
                                ============  ============   ==============



 The accompanying notes are an integral part of these financial statements.


/7/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 1 - Basis of presentation

The  consolidated  interim financial statements included  herein,
presented  in  accordance with United States  generally  accepted
accounting  principles  and  stated  in  US  dollars,  have  been
prepared by the Company, without audit, pursuant to the rules and
regulations  of the Securities and Exchange Commission.   Certain
information   and  footnote  disclosures  normally  included   in
financial   statements  prepared  in  accordance  with  generally
accepted  accounting  principles have been condensed  or  omitted
pursuant  to  such  rules and regulations, although  the  Company
believes   that  the  disclosures  are  adequate  to   make   the
information presented not misleading.

These  statements reflect all adjustments, consisting  of  normal
recurring  adjustments, which, in the opinion of management,  are
necessary  for  fair  presentation of the  information  contained
therein.   It  is  suggested  that  these  consolidated   interim
financial statements be read in conjunction with the consolidated
financial statements of the Company for the period ended December
31, 2002 and notes thereto included in the Company's Form 10-KSB.
The   Company  follows  the  same  accounting  policies  in   the
preparation of consolidated interim reports.

Results  of operations for the interim periods are not indicative
of annual results.

Note 2 - Going concern

The accompanying financial statements have been prepared assuming
that  the  Company  will  continue  as  a  going  concern,  which
contemplates the recoverability of assets and the satisfaction of
liabilities in the normal course of business. As noted above, the
Company is in the development stage and, accordingly, has not yet
generated  a  proven history of operations. Since its  inception,
the   Company   has  been  engaged  substantially  in   financing
activities and developing its product line, incurring substantial
costs and expenses. As a result, the Company incurred accumulated
net losses from July 6, 2000 (inception) through the period ended
June   30,   2003  of  $2,928,220.  In  addition,  the  Company's
development  activities  since inception  have  been  financially
sustained by capital contributions.

The  ability  of  the Company to continue as a going  concern  is
dependent upon its ability to raise additional capital  from  the
sale  of  common  stock  and,  ultimately,  the  achievement   of
significant   operating   results.  The  accompanying   financial
statements do not include any adjustments that might be  required
should  the Company be unable to recover the value of its  assets
or satisfy its liabilities.

Note 3 - Change in accounting principle

The  Company determined during the three months ending  June  30,
2003  that  it is appropriate to reclassify software acquired  in
2002  from intellectual property to fixed assets.  The effect  of
the  change in accounting principle requires a restatement of the
December  31,  2002  and March 31, 2003 financial  statements  in
order  to  properly  reflect the asset reclassification  and  the
related  adjustment to depreciation expense.  The effect of  this
change was to decrease net income for the year ended December 31,
2002  and  the three months ended March 31, 2003 by $119,988  and
$63,409, respectively.  Retained earnings as of January  1,  2002
has  been adjusted for the retroactive application of the  change
in accounting principle.

Note 4 - Fixed assets

On   February  5,  2003,  the  Company  acquired  fully-developed
software  valued  at  $181,250 from CareDecision.net,  Inc.,  the
former  parent corporation of Medicius, Inc.  Medicius, Inc.  was
acquired  by  the Company in June 2002. Several  of  the  control
persons  from CareDecision.net, Inc. are in similar positions  of
control at the Company.

Depreciation expense totaled $165,652 for the six-month period
ended June 30, 2003.


/8/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 5 - Notes payable - related party

During  the six months ended June 30, 2003, the Company  received
loans  totaling $113,791 from a Company shareholder and director.
The notes bear interest at 9% per annum and are due 365 days from
date of issuance.

During  the six months ended June 30, 2003, the Company  recorded
interest expense of $22,804.

Note 6 - Convertible notes

During the six months ended June 30, 2003, the Company received a
loan  totaling $50,000 from a Company shareholder.  The  note  is
convertible  into  1,538,500 shares of the Company's  $0.001  par
value  common stock at a strike price of $0.0325 per share.   The
convertible   note  also  carried  with  it  1,538,500   warrants
exercisable on a one-for-one basis at a strike price  of  $0.0325
per  share.  On April 22, 2003, the holder elected to convert the
note  into  1,538,500 shares of the Company's  $0.001  par  value
common stock.

Note 7 - Stockholder's equity

During  the  six  months ended June 30, 2003, the Company  issued
8,000,000  shares  of $0.001 par value common  stock  to  various
individuals for consulting services valued at $356,000.

During  the  six  months ended June 30, 2003, the Company  issued
2,500,000  shares  of $0.001 par value common  stock  to  acquire
developed software valued at $181,250 from CareDecision.net, Inc.

During  the  six  months ended June 30, 2003, the Company  issued
741,875  shares  of  its  $0.001 par value  common  stock  to  an
individual as settlement for past debts valued at $37,094.

There have been no other issuances of preferred or common stock.

Note 8 - Related party transactions

During  the six months ended June 30, 2003, the Company  acquired
fully-developed software from CareDecision.net,  Inc,  a  private
corporation  with  several  control persons  serving  in  similar
positions at the Company.  Pursuant to the agreement, the Company
paid  CareDecision.net, Inc. the sum of $181,250  with  2,500,000
shares of the Company's $0.001 par value common stock.

During  the six months ended June 30, 2003, the Company  received
$100,150  from Robert Cox, a Company shareholder and Chairman  of
the  Board.   The  notes are due on 365 days  from  issuance  and
accrued interest at 9% per annum.

During  the six months ended June 30, 2003, the Company  received
$50,000 from Dr. Thomas Chillemi, a Company shareholder, the note
is  convertible into 1,538,500 shares of the Company's $0.001 par
value  common  stock  and  carries  with  it  1,538,500  warrants
exercisable on a one-for-one basis at a strike price  at  $0.0325
per   share.  On  April  22,  2003  Dr.  Chillemi  exercised  the
convertible  portion of his note and converted the  $50,000  debt
into  1,538,500  shares of the Company's $.001 par  value  common
stock.

Note 9 - Stock option plan

On  January  1, 2003, the Company adopted its "2003 Stock  Option
Plan"  (the "Plan") and granted incentive and nonqualified  stock
options  with  rights  to  purchase  25,000,000  shares  of   the
Company's  $0.001  par value common stock.   The  Company  issued
8,000,000  shares of stock pursuant to the plan  during  the  six
months ended June 30, 2003.


/9/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 10 - Subsequent events

On July 21, 2003, the Company issued an 8% share dividend to
its  shareholders  of record.  The Company issued  6,469,132
shares of its $0.001 par value common stock pursuant to  the
dividend issuance.

On  July  1,  2003,  the Company entered into  a  consulting
agreement  with Anthony Quintiliana to perform   information
technology services for the Company.  As consideration,  the
Company  will  issue 1,500,000 shares of  $0.001  par  value
common  stock and stock options to purchase 2,000,000 shares
of  $0.001 par value common stock at a strike price of $0.05
per  share pursuant to the Company's 2003 Stock Option Plan.
The shares will be registered and free-trading via Form S-8.

On  July  1,  2003,  the Company entered into  a  consulting
agreement with Barbara Asbell to perform medical information
technology services for the Company.  As consideration,  the
Company  will  issue 4,000,000 shares of  $0.001  par  value
common  stock.   The  shares will be  registered  and  free-
trading  via  Form  S-8.   Based  upon  the  terms  of   her
consulting  agreements, Ms. Asbell has agreed to rescind  an
equal number of her existing legended, restricted shares.

On  July  10,  2003, the Company entered into  a  consulting
agreement   with   Thomas  Chillemi  to  perform   corporate
development services for the Company.  As consideration, the
Company  will  issue  stock options  to  purchase  3,000,000
shares of $0.001 par value common stock at a strike price of
$0.05  per share pursuant to the Company's 2003 Stock Option
Plan.   The  shares will be registered and free-trading  via
Form S-8.

On  July  15,  2003, the Company entered into  a  consulting
agreement  with  Dr.  Joseph  A.  Wolf  to  perform  medical
information   technology  services  for  the  Company.    As
consideration,  the  Company will  issue  stock  options  to
purchase 950,000 shares of $0.001 par value common stock  at
a  strike price of $0.05 per share pursuant to the Company's
2003  Stock Option Plan.  The shares will be registered  and
free-trading via Form S-8.

On  July  15,  2003, the Company entered into  a  consulting
agreement  with Leslie-Michelle Abraham to perform corporate
administrative  services for the Company.  As consideration,
the  Company  will  issue stock options to purchase  850,000
shares of $0.001 par value common stock at a strike price of
$0.05  per share pursuant to the Company's 2003 Stock Option
Plan.   The  shares will be registered and free-trading  via
Form S-8.

On  August  5,  2003, the Company entered into a  consulting
agreement  with  Ely Mandell to perform corporate  strategic
and   developmental   services   for   the   Company.     As
consideration,  the  Company will  issue  stock  options  to
purchase 150,000 shares of $0.001 par value common stock  at
a  strike price of $0.05 per share pursuant to the Company's
2003  Stock Option Plan.  The shares will be registered  and
free-trading via Form S-8.

Note  11  -  Reverse acquisitions agreement with  Medicius,  Inc.
(MED)

On  June 21, 2002, the Company entered into an agreement with MED
whereby  the  Company acquired all of the issued and  outstanding
common  stock of NDI in exchange for 38,043,863 voting shares  of
the Company's $0.001 par value common stock.  The acquisition was
accounted  for  using  the  purchase  method  of  accounting   as
applicable   to   reverse   acquisitions   because   the   former
stockholders  of  the MED controlled the Company's  common  stock
immediately  upon conclusion of the transaction.   Under  reverse
acquisition accounting, the post-acquisition entity was accounted
for  as  a recapitalization of MED.  The common stock issued  was
recorded  at $0, being the fair value of the Company's assets  on
the acquisition date.


/10/


     Item 2. Management's Discussion and Plan of Operation


Forward-Looking Statements

     This Quarterly Report contains forward-looking statements
about our business, financial condition and prospects that
reflect our assumptions and beliefs based on information
currently available.  We can give no assurance that the
expectations indicated by such forward-looking statements will be
realized.  If any of our assumptions should prove incorrect, or
if any of the risks and uncertainties underlying such
expectations should materialize, our actual results may differ
materially from those indicated by the forward-looking
statements.

     The key factors that are not within our control and that may
have a direct bearing on operating results include, but are not
limited to, acceptance of our services, our ability to expand our
customer base, our ability to raise capital in the future, the
retention of key employees and changes in the regulation of our
industry.  There may be other risks and circumstances that we are
unable to predict.  When used in this Quarterly Report, words
such as,  "believes,"  "expects,"  "intends,"  "plans,"
"anticipates,"  "estimates" and similar expressions are intended
to identify forward-looking statements, although there may be
certain forward-looking statements not accompanied by such
expressions.  All forward-looking statements are intended to be
covered by the safe harbor created by Section 21E of the
Securities Exchange Act of 1934.


General

     Our principal products are: an E-Health handheld information
appliance (PDA) software application package, and an E-commerce
handheld information appliance and network designed for the
hotel, motel and apartment marketplace.  We presently have a
comprehensive suite of medical information technology,
cooperative advertising, instant messaging and fulfillment, and
electronic commerce applications that are Internet enhanced,
integrated for medical professional use, and hotel
management/guest use, both software suites on a wireless PDA
Internet appliance.  These applications have been designed to
meet the needs of the inpatient and outpatient medical
environments, and the hotel management and guest (consumer), and
are not just commercially viable but also regulatory standard
compliant.  Additionally, our software applications were
conceived and implemented to offer the management level user,
either the medical professional or hotel manager, the ability to
prospective and retrospective commerce.

     Our software is designed to integrate point of service
applications.  The medical appliance, the longest available
product, monitors treatment protocols and up to the moment
patient histories coupled with real-time on-line medical
insurance claims submission.  Our ultimate key to success resides
in providing the private practice physician with the capability
to, sequentially, learn about the history of his or her patient
during, or prior to, entering the examining room, treat the
patient and update the insurer of the episode of care.
Accomplishing these objectives resolves a major dilemma for the
health care provider; instantaneous communication of vital
patient related information at or before the patient encounter.

     The hotel/motel and apartment software makes use of much of
the foundation technologies resident in the medical product,
however, given the differences in the two markets that the
products service, the hotel/motel product is much more
cooperative oriented, offering more consumer transactional
services with the compliment of advertising.


/11/


     Our technologies are grounded in the central need to furnish
the doctor with crucial point-of-care patient information rapidly
and reliably via a PDA.  It utilizes the power of the Internet to
move large amounts of data to and from a variety of platforms
securely via a powerful Windows CE based PDA designed for
portability and upgradability.  Totally compliant with the Health
Insurance Portability and Accountability Act of 1996 ("HIPAA"),
this PDA technology is among the first to offer complicated and
real-time point of care applications, previously legacy
(mainframe or PC network) system applications, on a totally
portable (PDA) appliance.

     Our PDA software operates on any Microsoft Windows CE
"Pocket PC" based handheld device, either in a wireless or
"wired" mode.  The local host for our PDA devices is a Windows
(9X, NT or later) based PC in the physician's office, which, in
turn, permits one to eight of the aforementioned PDAs to be
linked to either a medical network or hotel/motel wide area
network, and allows each PDA to become a uniquely identified
mobile node on that network, independent of PC linkage, thereby,
assisting the professional in the review of relevant histories,
transactions, and for the medical related product --medications
and prescriptions, lab test ordering, medical step processes and
protocols and specialist referral processes.

     The PDA software provides rules based software capabilities
and the ability to receive order fulfillment information for over
5,000 users simultaneously, which represents approximately 3
years of user encounters in a typical network setting, and allows
medical professionals to access payor and health plan business
rules, and policy/plan coverage's directly from the plan(s).


Results of Operations

     The following is an itemization of our results of operations
for the six-month period ended June 30, 2003.  In the comparable
period ended June 30, 2002, the Company had yet to begin
significant operations and therefore there were no expenses
associated with these items.

REVENUES. Total revenues for the six-month period ended June 30,
2003 were $1,850.  As a development stage company we have yet to
generate significant revenues and we cannot guarantee with
certainty when we will begin to generate significant revenues.
Our future revenues will be reliant on the acceptance of our
software systems, communication tools and suite of software
applications.

GENERAL AND ADMINISTRATIVE. General and Administrative expenses
relate to the operation and leasing costs of our corporate
office.  General and administrative expenses for the six-month
period ended June 30, 2003 were $83,989 compared to $182,849 for
the six-month period ended June 30, 2002.  General and
Administrative expenses decreased by approximately 54% from the
comparable period as the Company consolidated operations after
its merger in 2002.  The company, in anticipation of its merger
made purchases of equipment and other office related supplies in
conjunction with the start of initial business operations in the
six-month period ended June 30, 2002.

PAYROLL. Payroll expense consists primarily of management and
employee salaries.  Total payroll expense for the six-month
period ended June 30, 2003 was $122,794.  The Company incurred no
payroll expense for the six-month period ended June 30, 2002.

PROFESSIONAL FEES. Professional fees include fees paid to our
accountants and attorneys.  Our professional fees were $43,228
for the six-month period ended June 30, 2003.  The Company
incurred no professional fees for the six-month period ended June
30, 2002.


/12/


CONSULTING. Consulting expense includes fees paid to consultants
in relation to the preparation of required SEC filings, and to
individuals engaged to assist management in the furtherance of
our business plan.  Consulting expenses for the six-month period
ended June 30, 2003 were $356,000 compared to $409,446 for the
six-month period ended June 30, 2002.  Consulting expense
decreased by approximately 13% from the comparable period as the
Company has consolidated the use of consultants after its merger
to assist in the furtherance of our business model.

SOFTWARE DEVELOPMENT. Software Development expense was minimal as
our software systems; communication tools and suite of software
applications are complete.  Software Development expense for the
six-month period ended June 30, 2003 was $3,950.  The Company
incurred no software development expense for the six-month period
ended June 30, 2002.

DEPRECIATION. Depreciation was $165,652 for the six-month period
ended June 30, 2003 compared to $1,393 for the six-month period
ended June 30, 2002.  This represents depreciation on the assets
of the Company.  Depreciation expense has increased significantly
from the comparable period due to the assets purchased in the six-
month period ended June 30, 2002, which are now on depreciation
schedules.

TOTAL OPERATING EXPENSES. Total operating expenses for the six-
month period ended June 30, 2003 were $775,613 compared to
$593,688 for the six-month period ended June 30, 2002.  Total
operating expenses increased by approximately 31% due mainly to
our addition of staff and subsequent incurrence of payroll
expense and the increase in depreciation expense on the assets of
the Company.  Our most significant operating expenses are
consulting, payroll and depreciation expenses.

LOSS ON DEBT SETTLEMENT. In the six-month period ended June 30,
2003 the Company retired past debts valued at $37,094.  There was
no debt retired in the comparable six-month period ended June 30,
2002.

INTEREST INCOME. Interest income was $561 for the six-month
period ended June 30, 2003 compared to $967 for the six-month
period ended June 30, 2002.

INTEREST EXPENSE. Interest expense was $22,804 for the six-month
period ended June 30, 2003 compared to $8,251 for the six-month
period ended June 30, 2002.  Interest expense increased
significantly as a result of the receipt of loans totaling
$113,791 in the six-month period ended June 30, 2003 that bear an
interest rate of 9%.

LOSS FROM OPERATIONS/NET LOSS. Our loss from operations was
$833,100 for the six-month period ended March 31, 2003 compared
to $599,917 for the six-month period ended June 30, 2002.  It
should be expected that we will continue to incur losses from
operations until such time as revenues can be generated to cover
such costs.

Future Business

     The elements of our future business strategy include:
expanding geographically into key markets through a combination
of opening new offices and developing relationships with clients
to generate demand for our services, particularly for the
company's hotel/motel and apartment products; recruiting
qualified, medical software and other technical personnel to
perform technical, implementation and support duties as contracts
are entered into, although there can be no assurance that any
such contracts will be secured; and pursuing entry into new
markets complementary to our proposed operations.  Future
operations are dependent upon our ability to implement our
business and marketing strategies and to establish relationships
and contracts with health insurers and HMOs to provide our e-
healthcare products and services, and to establish relationships
with large hotel and/or motel chains for our hotel/motel
products.


/13/


Liquidity and Capital Resources

     Management believes our cash on hand of $11,913 will not be
sufficient to fund ongoing fiscal 2003 and 2004 operations and
provide for our working capital needs given we have negative
working capital of $635,261.  Thus we will from time to time need
to raise additional funds through capital markets.  Our
accountant has issued a note concerning our ability to continue
as a going concern.  As we are still considered to be in the
development stage, our prospects of continuing as a going concern
are contingent upon our ability to raise additional capital and
to achieve and maintain profitable operations.  Revenues
generated over and above expenses will be used for further
development of our services, to provide financing for marketing
and promotion, to secure additional customers, equipment and
personnel, and for other working capital purposes.

     To date, we have financed our cash flow requirements through
an issuance of common stock and through the issuance of notes.
During the six months ended June 30, 2003, we received loans
totaling $113,791 from a Company shareholder and director.  The
notes bear interest at 9% per annum and are due 365 days from
date of issuance.  In addition, during the six months ended June
30, 2003, we received $100,150 from Robert Cox, President of
CareDecision Corporation.  This note bears an interest rate of 9%
per annum and is due 365 days from date of issuance.

     During our normal course of business, we will experience net
negative cash flows from operations, pending receipt of revenues.
Further, we will be obtaining financing to fund operations
through additional common stock offerings, note issuances and
bank borrowings, to the extent available, or to obtain additional
financing to the extent necessary to augment our available cash
on hand.

     All investor inquiries should be directed via mail to Mr.
Robert Cox, President, CareDecision Corporation, 2660 Townsgate
Road, Suite 300, Westlake Village, California 91361.



         [balance of this page intentionally left blank]


/14/


                   PART II - OTHER INFORMATION


     Item 6(a) - Exhibits



  Exhibit  Name and/or Identification of Exhibit
  Number
   3.1     Articles of Incorporation & By-Laws
             (a) Articles of Incorporation of the Company
             filed March 2, 2001.  Incorporated by reference
             to the exhibits to the Company's General Form For
             Registration Of Securities Of Small Business
             Issuers on Form 10-SB, previously filed with the
             Commission.
             (b) Certificate of Amendment to the Articles of
             Incorporation of the Company filed May 9, 2001.
             Incorporated by reference to the exhibits to the
             Company's General Form For Registration Of
             Securities Of Small Business Issuers on Form 10-
             SB, previously filed with the Commission.
             (c) Certificate of Amendment to the Articles of
             Incorporation of the Company filed August 2,
             2002.  Incorporated by reference to the exhibits
             to the Company's June 30, 2002 Quarterly Report
             on Form 10-QSB, previously filed with the
             Commission.
   3.2      By-Laws of the Company adopted March 16, 2001.
            Incorporated by reference to the exhibits to the
            Company's General Form For Registration Of
            Securities Of Small Business Issuers on Form
            10-SB, previously filed with the Commission.
  31        Rule 13a-14(a)/15d-14(a) Certification
  32        Certification under Section 906 of the Sarbanes-
            Oxley Act (SECTION 1350)


     Item 6(b) - Reports Filed on Form 8-K

     For the quarter ended June 30, 2003 the Company filed a
report on Form 8-K with the Securities and Exchange Commission on
May 20, 2003.  The Company reported under Item 9. Regulation FD
Disclosures that they had signed an agreement with associated
hotel owners throughout Minnesota and North Dakota.  Further,
under Item 7. Financial Statements and Exhibits the Company filed
the Agreement dated April 20, 2003 by and between CareDecision
Corporation and the corresponding hotel/motel owners and
residence centers.  No financial statements were included in this
report.


/15/


                           SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

                    CareDecision Corporation
-----------------------------------------------------------------
                          (Registrant)




Date: August 13, 2003
      ---------------



By: /s/ Robert Cox
   ------------------
    Robert Cox
    President and CEO





Date: August 13, 2003
      ---------------



By: /s/ Keith Berman
   ------------------
    Keith Berman
    Secretary and Treasurer/CFO


/16/